Table 1.
Criterion |
---|
Left ventricular ejection fraction <50% |
Left ventricular enlargement (echo-derived left ventricular end-diastolic dimension ≥95th percentile for gender/height)35 |
|
Exclusion of all of the following at the time of primary DCM diagnosis: |
|
Coronary artery disease (CAD) causing ischemic cardiomyopathy (>50% narrowing, any major epicardial coronary artery; clinical testing is indicated to exclude CAD routinely in (1) males >40 years or females >45 years without risk factors and (2) males or females >30 years with risk factors) |
Primary valvular disease |
Cardiotoxic drug exposure, including Adriamycin and other cancer chemotherapeutics |
Other forms of cardiomyopathy (e.g., hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, restrictive cardiomyopathy, Chagas cardiomyopathy) |
Congenital/structural heart disease |
Sarcoid |
Amyloid |
Iron overload |
Other active multisystem disease that may plausibly cause DCM (e.g., hypereosinophilic syndrome, cardiac involvement with connective tissue disease, Loeffler’s endocarditis, endomyocardial fibrosis) |
Severe and untreated or untreatable hypertension* |
Exclusion beyond a reasonable doubt of all other detectable causes of cardiomyopathy (other than genetic) at the time of primary DCM diagnosis using a rigorous clinical standard congruent with an expert approach rendered by a board-certified heart failure/transplant cardiologist |
DCM = Dilated cardiomyopathy.
Severe hypertension is defined as systolic blood pressures routinely >180 mm Hg and/or diastolic blood pressures >120 mm Hg. Untreated hypertension is an individual receiving no medications, and untreatable hypertension is an individual with severe hypertension persisting despite multidrug regimens and/or associated with other multisystem disease (e.g., scleroderma, other vasculitides, etc).